Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
CARDIOTHORACIC	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Chest	O
Pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
1.	O
Coronary	O
artery	O
bypass	O
graft	O
x	O
4.	O
Total	O
arterial	O
revascularization.	O
2.	O
Skeletonized	O
left	O
internal	O
mammary	O
artery	O
sequential	O
grafting	O
to	O
the	O
diagonal	O
and	O
the	O
left	O
anterior	O
descending	O
artery.	O
3.	O
Skeletonized	O
free	O
right	O
internal	O
mammary	O
artery.	O
He	O
has	O
had	O
T	O
graft	O
off	O
the	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
distal	O
circumflex.	O
4.	O
Left	O
radial	O
artery	O
grafting	O
to	O
posterior	O
descending	O
artery.	O
5.	O
Endoscopic	O
harvesting	O
of	O
the	O
left	O
radial	O
artery.	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
year	O
old	O
male	O
with	O
past	O
medical	O
history	O
of	O
diabetes	O
mellitus	O
type	O
2,	O
hypertension,	O
hyperlipidemia,	O
and	O
renal	O
cell	O
carcinoma	O
status	O
post	O
recent	O
partial	O
nephrectomy.	O
He	O
presented	O
to	O
___	O
with	O
chest	O
pain.	O
A	O
stress	O
test	O
was	O
positive	O
with	O
inferolateral	O
ischemia,	O
moderate	O
size,	O
moderate	O
reversibility	O
and	O
overall	O
normal	O
LV	O
systolic	O
function	O
with	O
an	O
ejection	O
fraction	O
of	O
55%.	O
He	O
ruled	O
in	O
for	O
non-ST	O
elevation	O
myocardial	O
infarction	O
and	O
was	O
transferred	O
to	O
___	O
for	O
cardiac	O
catheterization.	O
The	O
study	O
revealed	O
three-vessel	O
coronary	O
artery	O
disease.	O
Cardiac	O
surgery	O
was	O
consulted	O
for	O
coronary	O
artery	O
bypass	O
graft	O
evaluation.	O
Past	O
Medical	O
History:	O
Primary:	O
Coronary	O
Artery	O
Disease/Non-ST	O
Elevation	O
Myocardial	O
Infarction	O
s/p	O
CABG	O
x4	O
Secondary:	O
Back	O
Pain	O
Chronic	O
Obstructive	O
Pulmonary	O
Disease	O
Diabetes	O
Mellitus	O
Type	O
II	O
Hyperlipidemia	O
Hypertension	O
Knee	O
Pain	O
Obstructive	O
Sleep	O
Apnea	O
Renal	O
Cell	O
Carcinoma	O
Surgical	O
History:	O
Appendectomy	O
___	O
Fracture	O
ORIF	O
Knee	O
Surgery	O
Partial	O
Nephrectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
-	O
history	O
of	O
coronary	O
artery	O
disease	O
Physical	O
Exam:	O
Admit	O
PE:	O
BP:	O
121/80.	O
HR:	O
102.	O
RR:	O
12.	O
O2	O
sat:	O
95%	O
RA	O
Height:	O
75"	O
Weight:	O
225	O
lbs	O
General:	O
Skin:	O
Dry	O
[x]	O
intact	O
[x]	O
HEENT:	O
PERRLA	O
[x]	O
EOMI	O
[x]	O
Neck:	O
Supple	O
[x]	O
Full	O
ROM	O
[x]	O
Chest:	O
Lungs	O
clear	O
bilaterally	O
[x]	O
Heart:	O
RRR	O
[x]	O
Irregular	O
[]	O
Murmur	O
[]	O
grade	O
______	O
Abdomen:	O
Soft	O
[x]	O
non-distended	O
[x]	O
non-tender	O
[x]	O
bowel	O
sounds	O
+[x]	O
Extremities:	O
Warm	O
[x],	O
well-perfused	O
[x]	O
Edema	O
[]	O
Varicosities:	O
None	O
[x]	O
Neuro:	O
Grossly	O
intact	O
[x]	O
Pulses:	O
Femoral	O
Right:1+	O
Left:1+	O
DP	O
Right:1+	O
Left:1+	O
___	O
Right:1+	O
Left:1+	O
Radial	O
Right:1+	O
Left:1+	O
Carotid	O
Bruit:	O
Right:	O
-	O
Left:-	O
Discharge	O
Exam:	O
Vital	O
Signs	O
___	O
@	O
826)	O
Temp:	O
97.8,	O
BP:	O
127/76,	O
HR:	O
89,	O
RR:	O
18,	O
O2	O
sat:	O
96%	O
RA,	O
Wt:	O
218.92	O
lb/99.3	O
kg	O
Admission	O
Weight:	O
225	O
lbs/102.6kg	O
General:	O
NAD	O
[x]	O
Neurological:	O
A/O	B-Delirium
x3	B-Delirium
[x]	O
non-focal	O
[]	O
HEENT:	O
PEERL	O
[x]	O
Cardiovascular:	O
RRR	O
[x]	O
Irregular	O
[]	O
Murmur	O
[]	O
Rub	O
[]	O
Respiratory:	O
CTA	O
[x]diminished	O
bases.	O
No	O
resp	O
distress	O
[x]	O
GI/Abdomen:	O
Bowel	O
sounds	O
present	O
[x]	O
Soft	O
[x]	O
ND	O
[x]	O
NT	O
[x]	O
Extremities:	O
Right	O
Upper	O
extremity	O
Warm	O
[x]	O
Edema	O
-	O
Left	O
Upper	O
extremity	O
Warm	O
[x]	O
Edema	O
-	O
Right	O
Lower	O
extremity	O
Warm	O
[x]	O
Edema	O
-	O
Left	O
Lower	O
extremity	O
Warm	O
[x]	O
Edema	O
-	O
Pulses:	O
DP	O
Right:	O
+	O
Left:	O
+	O
___	O
Right:	O
+	O
Left:	O
+	O
Radial	O
Right:	O
+	O
Left:	O
+	O
Skin/Wounds:	O
Dry	O
[x]	O
intact	O
[x]	O
Sternal:	O
CDI	O
[]	O
no	O
erythema	O
or	O
drainage	O
[]	O
Sternum	O
stable	O
[x]	O
Prevena	O
[x]	O
Lower	O
extremity:	O
Right	O
[]	O
Left	O
[]	O
CDI	O
[]	O
Upper	O
extremity:	O
Right	O
[]	O
Left	O
[x]	O
CDI	O
[x]	O
Pertinent	O
Results:	O
STUDIES:	O
Cardiac	O
Catheterization	O
___	O
right	O
dominant	O
LM:	O
70%	O
stenosis	O
in	O
the	O
mid	O
and	O
distal	O
segments.	O
LAD:	O
70%	O
stenosis	O
in	O
the	O
mid	O
segment.	O
LCx:	O
70%	O
stenosis	O
in	O
the	O
mid	O
and	O
distal	O
segments.	O
OM1	O
and	O
OM2	O
are	O
medium	O
caliber	O
vessels.	O
RCA:	O
95%	O
stenosis	O
in	O
the	O
distal	O
segment.	O
Collaterals	O
from	O
the	O
distal	O
segment	O
of	O
the	O
LAD	O
connect	O
to	O
the	O
distal	O
segment.	O
The	O
SinoAtrial,	O
arising	O
from	O
the	O
proximal	O
segment,	O
is	O
a	O
small	O
caliber	O
vessel.	O
RPDA	O
is	O
a	O
medium	O
caliber	O
vessel.	O
Carotid	O
Ultrasound	O
___	O
There	O
is	O
less	O
than	O
40%	O
stenosis	O
within	O
the	O
internal	O
carotid	O
arteries	O
bilaterally.	O
Transthoracic	O
Echocardiogram	O
___	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
normal.	O
There	O
is	O
no	O
evidence	O
for	O
an	O
atrial	O
septal	O
defect	O
by	O
2D/color	O
Doppler.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
___	O
mmHg.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
hypokinesis	O
of	O
the	O
basal	O
inferior	O
and	O
inferolateral	O
segments	O
(see	O
schematic).	O
Quantitative	O
biplane	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
50	O
%.	O
Left	O
ventricular	O
cardiac	O
index	O
is	O
normal	O
(>2.5	O
L/min/m2).	O
There	O
is	O
no	O
resting	O
left	O
ventricular	O
outflow	O
tract	O
gradient.	O
No	O
ventricular	O
septal	O
defect	O
is	O
seen.	O
Diastolic	O
parameters	O
are	O
indeterminate.	O
Normal	O
right	O
ventricular	O
cavity	O
size	O
with	O
normal	O
free	O
wall	O
motion.	O
The	O
aortic	O
sinus	O
diameter	O
is	O
normal	O
for	O
gender	O
with	O
normal	O
ascending	O
aorta	O
diameter	O
for	O
gender.	O
The	O
aortic	O
arch	O
is	O
mildly	O
dilated.	O
There	O
is	O
no	O
evidence	O
for	O
an	O
aortic	O
arch	O
coarctation.	O
The	O
aortic	O
valve	O
leaflets	O
(?#)	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
There	O
is	O
trace	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
appear	O
structurally	O
normal	O
with	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
trivial	O
mitral	O
regurgitation.	O
The	O
tricuspid	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
physiologic	O
tricuspid	O
regurgitation.	O
The	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
estimated.	O
There	O
is	O
a	O
very	O
small	O
pericardial	O
effusion.	O
IMPRESSION:	O
Mild	O
regional	O
systolic	O
dysfunction.	O
No	O
clinically	O
significant	O
valvular	O
regurgitation	O
or	O
stenosis.	O
Indeterminate	O
pulmonary	O
pressure.	O
PA/LAT	O
CXR	O
___	O
-Small	O
subpulmonic	O
left	O
pleural	O
effusion	O
has	O
increased	O
while	O
fissural	O
component	O
has	O
resolved.	O
Left	O
basal	O
atelectasis	O
is	O
mild.	O
Right	O
lung	O
and	O
pleural	O
space	O
are	O
normal.	O
Normal	O
postoperative	O
cardiomediastinal	O
silhouette.	O
=	O
================================================================	O
Admission	O
Labs:	O
___	O
06:10AM	O
BLOOD	O
WBC-8.4	O
RBC-4.77	O
Hgb-14.1	O
Hct-41.7	O
MCV-87	O
MCH-29.6	O
MCHC-33.8	O
RDW-13.6	O
RDWSD-43.5	O
Plt	O
___	O
___	O
06:10AM	O
BLOOD	O
___	O
PTT-31.2	O
___	O
___	O
06:10AM	O
BLOOD	O
Glucose-192*	O
UreaN-15	O
Creat-0.8	O
Na-141	O
K-4.7	O
Cl-104	O
HCO3-20*	O
AnGap-17	O
___	O
06:10AM	O
BLOOD	O
ALT-51*	O
AST-38	O
LD(LDH)-200	O
AlkPhos-58	O
TotBili-0.5	O
___	O
06:10AM	O
BLOOD	O
Albumin-4.3	O
Calcium-8.8	O
Phos-3.4	O
Mg-1.4*	O
___	O
06:10AM	O
BLOOD	O
%HbA1c-8.7*	O
eAG-203*	O
Discharge	O
Labs:	O
___	O
04:45AM	O
BLOOD	O
WBC-15.8*	O
RBC-3.32*	O
Hgb-9.9*	O
Hct-30.2*	O
MCV-91	O
MCH-29.8	O
MCHC-32.8	O
RDW-14.3	O
RDWSD-46.5*	O
Plt	O
___	O
___	O
04:45AM	O
BLOOD	O
Glucose-101*	O
UreaN-23*	O
Creat-0.8	O
Na-134*	O
K-4.1	O
Cl-94*	O
HCO3-26	O
AnGap-14	O
___	O
04:45AM	O
BLOOD	O
Mg-1.___	O
yo	O
male	O
presenting	O
with	O
worsening	O
pattern	O
of	O
exertional	O
CP/SOB	O
with	O
increased	O
cardiac	O
biomarkers	O
and	O
EKG	O
with	O
inferior	O
lead	O
Q	O
waves	O
more	O
pronounced	O
than	O
last	O
TTE	O
in	O
___,	O
stress	O
MIBI	O
at	O
___	O
positive	O
for	O
inferolateral	O
ischemia	O
and	O
cor	O
angio	O
___	O
at	O
___	O
showing	O
triple	O
vessel	O
disease.	O
He	O
received	O
ASA	O
325mg	O
and	O
was	O
started	O
on	O
atorvastatin	O
at	O
the	O
outside	O
hospital.	O
We	O
continued	O
the	O
atorvastatin	O
and	O
his	O
home	O
ASA	O
81mg/day.	O
He	O
started	O
metoprolol	O
tartrate	O
titrated	O
up	O
to	O
12.5mg	O
QID,	O
and	O
started	O
a	O
heparin	O
gtt	O
leading	O
up	O
to	O
CABG	O
given	O
that	O
the	O
patient	O
had	O
a	O
brief	O
recurrence	O
of	O
CP.	O
He	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
___.	O
He	O
underwent	O
coronary	O
artery	O
bypass	O
grafting	O
x4.	O
Please	O
see	O
operative	O
note	O
for	O
full	O
details.	O
In	O
summary	O
he	O
had:	O
1.	O
Coronary	O
artery	O
bypass	O
graft	O
x	O
4.	O
Total	O
arterial	O
revascularization.	O
2.	O
Skeletonized	O
left	O
internal	O
mammary	O
artery	O
sequential	O
grafting	O
to	O
the	O
diagonal	O
and	O
the	O
left	O
anterior	O
descending	O
artery.	O
3.	O
Skeletonized	O
free	O
right	O
internal	O
mammary	O
artery	O
as	O
a	O
T	O
graft	O
off	O
the	O
left	O
internal	O
mammary	O
artery	O
to	O
the	O
distal	O
circumflex.	O
4.	O
Left	O
radial	O
artery	O
grafting	O
to	O
posterior	O
descending	O
artery.	O
5.	O
Endoscopic	O
harvesting	O
of	O
the	O
left	O
radial	O
artery.	O
He	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
CVICU	O
in	O
stable	O
condition	O
for	O
recovery	O
and	O
invasive	O
monitoring.	O
He	O
weaned	O
from	O
sedation,	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	O
on	O
the	O
day	O
of	O
surgery.	O
He	O
was	O
weaned	O
from	O
intravenous	O
medications,	O
Beta	O
blocker	O
and	O
nitrates	O
were	O
initiated	O
and	O
he	O
was	O
diuresed	O
toward	O
his	O
preoperative	O
weight.	O
He	O
remained	O
hemodynamically	O
stable	O
and	O
was	O
transferred	O
to	O
the	O
telemetry	O
floor	O
for	O
further	O
recovery.	O
Beta	O
blockers	O
were	O
titrated	O
up	O
with	O
HR	O
>100	O
for	O
several	O
days.	O
He	O
was	O
transitioned	O
from	O
nitroglycerin	O
to	O
Imdur	O
for	O
radial	O
artery	O
graft,	O
and	O
should	O
continue	O
this	O
for	O
3	O
months	O
postop.	O
ACE-I	O
was	O
started	O
with	O
preop	O
NSTEMI.	O
He	O
was	O
restarted	O
on	O
his	O
home	O
oral	O
diabetic	O
medications	O
and	O
Lantus	O
for	O
hyperglycemia.	O
Chest	O
tubes	O
remained	O
in	O
an	O
additional	O
day	O
due	O
to	O
high	O
serous	O
drainage.	O
Chest	O
tubes	O
and	O
pacing	O
wires	O
were	O
removed	O
per	O
cardiac	O
surgery	O
protocol	O
without	O
complication.	O
He	O
was	O
evaluated	O
by	O
the	O
physical	O
therapy	O
service	O
for	O
assistance	O
with	O
strength	O
and	O
mobility.	O
By	O
the	O
time	O
of	O
discharge	O
on	O
POD	O
4	O
he	O
was	O
ambulating	B-Mobile_with_assistance
with	O
assistance,	B-Mobile_with_assistance
the	O
wound	O
was	O
healing,	O
and	O
pain	O
was	O
controlled	O
with	O
oral	O
analgesics.	O
He	O
was	O
discharged	O
to	O
___	O
at	O
___	O
in	O
good	O
condition	O
with	O
appropriate	O
follow	O
up	O
instructions.	O
Prevena	O
should	O
be	O
removed	O
on	O
POD	O
7	O
(___).	O
Medications	O
on	O
Admission:	O
1.	O
Albuterol	O
Inhaler	O
1	O
PUFF	O
IH	O
Q4H:PRN	O
SOB,	O
wheezing	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Fluticasone-Salmeterol	O
Diskus	O
(100/50)	O
1	O
INH	O
IH	O
BID	O
4.	O
Gabapentin	O
1200	O
mg	O
PO	O
BID	O
5.	O
Lantus	O
U-100	O
Insulin	O
(insulin	O
glargine)	O
40	O
units	O
subcutaneous	O
QHS	O
6.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
7.	O
Simvastatin	O
20	O
mg	O
PO	O
QPM	O
8.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
9.	O
Lisinopril	O
20	O
mg	O
PO	O
DAILY	O
10.	O
coenzyme	O
Q10	O
10	O
mg	O
oral	O
DAILY	O
11.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
12.	O
Vitamin	O
B	O
Complex	O
1	O
CAP	O
PO	O
DAILY	O
13.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
14.	O
Ibuprofen	O
600	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
-	O
Mild	O
15.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
2.	O
Bisacodyl	O
___AILY:PRN	O
constipation	O
3.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
Duration:	O
2	O
Weeks	O
4.	O
Isosorbide	O
Dinitrate	O
5	O
mg	O
PO	O
TID	O
5.	O
Metoprolol	O
Tartrate	O
100	O
mg	O
PO	O
TID	O
6.	O
OxyCODONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q6H:PRN	O
Pain:	O
moderate/severe	O
RX	O
*oxycodone	O
5	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*50	O
Tablet	O
Refills:*0	O
7.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
8.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
DAILY	O
Duration:	O
2	O
Weeks	O
Hold	O
for	O
K	O
>4.5	O
9.	O
Ranitidine	O
150	O
mg	O
PO	O
BID	O
Duration:	O
1	O
Month	O
10.	O
Senna	O
17.2	O
mg	O
PO	O
DAILY	O
11.	O
Glargine	O
45	O
Units	O
Bedtime	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
REG	O
Insulin	O
12.	O
Lisinopril	O
2.5	O
mg	O
PO	O
DAILY	O
13.	O
Albuterol	O
Inhaler	O
1	O
PUFF	O
IH	O
Q4H:PRN	O
SOB,	O
wheezing	O
14.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
15.	O
coenzyme	O
Q10	O
10	O
mg	O
oral	O
DAILY	O
16.	O
Cyclobenzaprine	O
10	O
mg	O
PO	O
HS:PRN	O
Muscle	O
spasm	O
17.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY	O
18.	O
Fluticasone-Salmeterol	O
Diskus	O
(100/50)	O
1	O
INH	O
IH	O
BID	O
19.	O
Gabapentin	O
1200	O
mg	O
PO	O
BID	O
20.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
21.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
22.	O
Simvastatin	O
20	O
mg	O
PO	O
QPM	O
23.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
QHS	O
24.	O
Tiotropium	O
Bromide	O
1	O
CAP	O
IH	O
DAILY	O
25.	O
Vitamin	O
B	O
Complex	O
1	O
CAP	O
PO	O
DAILY	O
26.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
Primary:	O
Coronary	O
Artery	O
Disease/Non-ST	O
Elevation	O
Myocardial	O
Infarction	O
s/p	O
CABG	O
x4	O
Secondary:	O
Back	O
Pain	O
Chronic	O
Obstructive	O
Pulmonary	O
Disease	O
Diabetes	O
Mellitus	O
Type	O
II	O
Hyperlipidemia	O
Hypertension	O
Knee	O
Pain	O
Obstructive	O
Sleep	O
Apnea	O
Renal	O
Cell	O
Carcinoma	O
Discharge	O
Condition:	O
Alert	O
and	O
oriented	B-Delirium
x3	O
nonfocal	O
Ambulating,	O
gait	O
steady	O
Sternal	O
pain	O
managed	O
with	O
oral	O
analgesics	O
Sternal	O
Incision	O
-	O
healing	O
well,	O
Prevena	O
Edema-1+	O
Discharge	O
Instructions:	O
Please	O
shower	O
daily	O
-wash	O
incisions	O
gently	O
with	O
mild	O
soap,	O
no	O
baths	O
or	O
swimming,	O
look	O
at	O
your	O
incisions	O
daily	O
Please	O
-	O
NO	O
lotion,	O
cream,	O
powder	O
or	O
ointment	O
to	O
incisions	O
Each	O
morning	O
you	O
should	O
weigh	O
yourself	O
and	O
then	O
in	O
the	O
evening	O
take	O
your	O
temperature,	O
these	O
should	O
be	O
written	O
down	O
on	O
the	O
chart	O
No	O
driving	O
for	O
one	O
month	O
or	O
while	O
taking	O
narcotics.	O
Clearance	O
to	O
drive	O
will	O
be	O
discussed	O
at	O
follow	O
up	O
appointment	O
with	O
surgeon	O
No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
Encourage	O
full	O
shoulder	O
range	O
of	O
motion,	O
unless	O
otherwise	O
specified	O
**Please	O
call	O
cardiac	O
surgery	O
office	O
with	O
any	O
questions	O
or	O
concerns	O
___.	O
Answering	O
service	O
will	O
contact	O
on	O
call	O
person	O
during	O
off	O
hours**	O
Prevena	O
instructions	O
Â·	O
The	O
Prevena	O
Wound	O
dressing	O
should	O
be	O
left	O
on	O
for	O
a	O
total	O
of	O
7	O
days	O
post-operatively	O
to	O
receive	O
the	O
full	O
benefit	O
of	O
the	O
therapy.	O
The	O
date	O
of	O
Day	O
#	O
7	O
(___)	O
should	O
be	O
written	O
on	O
a	O
piece	O
of	O
tape	O
on	O
the	O
canister	O
to	O
ensure	O
that	O
the	O
nurse	O
from	O
the	O
___	O
or	O
___	O
facility	O
knows	O
when	O
to	O
remove	O
the	O
dressing	O
and	O
inspect	O
the	O
incision.	O
If	O
the	O
date	O
is	O
not	O
written,	O
please	O
alert	O
your	O
nurse	O
prior	O
to	O
discharge.	O
-	O
You	O
may	O
shower,	O
however,	O
please	O
avoid	O
getting	O
the	O
dressing	O
and	O
suction	O
canister	O
soiled	O
or	O
saturated.	O
-	O
You	O
will	O
be	O
sent	O
home	O
with	O
a	O
shower	O
bag	O
to	O
hold	O
the	O
suction	O
canister	O
while	O
bathing.	O
-	O
If	O
the	O
dressing	O
does	O
become	O
soiled	O
or	O
saturated,	O
turn	O
the	O
power	O
off	O
and	O
remove	O
the	O
dressing.	O
The	O
entire	O
unit	O
may	O
then	O
be	O
discarded.	O
Should	O
this	O
happen,	O
please	O
notify	O
your	O
___	O
nurse,	O
so	O
they	O
may	O
make	O
plans	O
to	O
see	O
you	O
the	O
following	O
day	O
to	O
assess	O
your	O
incision.	O
-	O
Once	O
the	O
Prevena	O
dressing	O
is	O
removed,	O
you	O
may	O
wash	O
your	O
incision	O
daily	O
with	O
a	O
plain	O
white	O
bar	O
soap,	O
such	O
as	O
Dove	O
or	O
___.	O
Do	O
not	O
apply	O
any	O
creams,	O
lotions	O
or	O
powders	O
to	O
your	O
incision	O
and	O
monitor	O
it	O
daily.	O
-	O
If	O
you	O
notice	O
any	O
redness,	O
swelling	O
or	O
drainage,	O
please	O
contact	O
your	O
surgeon's	O
office	O
at	O
___.	O
Followup	O
Instructions:	O
___	O

